DR. RON S. BAKAL MD
Prescription History 1477579639
Urology in New York, NY
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. RON S. BAKAL MD, an active Urology specialist practicing in New York, NY. Our medical registry currently tracks 8 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 282 documented patient claims. Among these therapy options, the most frequently utilized medication is Tamsulosin Hcl, which accounts for 85 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other NY PrescribersVs. NY Avg |
|---|---|---|---|
| Tamsulosin Hcl | 85 | $17.42▼ below NY avg | ≈ Typical |
About Tamsulosin Hcl: Tamsulosin is used by men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). Show more ▾ It does not shrink the prostate, but it works by relaxing the muscles in the prostate and the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Tamsulosin belongs to a class of drugs known as alpha blockers. Do not use this medication to treat high blood pressure. In 2023, this provider wrote 85 Medicare prescriptions for Tamsulosin Hcl, about the same volume as the typical New York prescriber of this medication (92). Medicare paid an average of $17.42 per fill, versus $19.45 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 139 30-Day Fills standardized to 30-day supplies 4,170 Days of Medication total across all patients in 2023 | |||
| Finasteride | 57 | $12.17▼ below NY avg | ≈ Typical |
About Finasteride: Finasteride is used to shrink an enlarged prostate (benign prostatic hyperplasia or BPH) in adult men. Show more ▾ It may be used alone or taken in combination with other medications to reduce symptoms of BPH and may also reduce the need for surgery. Finasteride may improve symptoms of BPH and provide benefits such as decreased urge to urinate, better urine flow with less straining, less of a feeling that the bladder is not completely emptied, and decreased nighttime urination. This medication works by decreasing the amount of a natural body hormone (DHT) that causes growth of the prostate. Finasteride is not approved for prevention of prostate cancer. It may slightly increase the risk of developing a very serious form of prostate cancer. Talk to your doctor about the benefits and risks. Women and children should not use this medication. An orally active 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE inhibitor. It is used as a surgical alternative for treatment of benign PROSTATIC HYPERPLASIA. In 2023, this provider wrote 57 Medicare prescriptions for Finasteride, about the same volume as the typical New York prescriber of this medication (62). Medicare paid an average of $12.17 per fill, versus $15.53 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 113 30-Day Fills standardized to 30-day supplies 3,390 Days of Medication total across all patients in 2023 | |||
| ToviazFesoterodine Fumarate | 41 | $410.00▼ below NY avg | ▲ More than typical |
About Toviaz: This medication is used to treat certain bladder problems (overactive bladder, neurogenic detrusor overactivity). Show more ▾ Overactive bladder is a problem with how your bladder stores urine. Neurogenic detrusor overactivity is a bladder control condition caused by brain, spinal cord, or nerve problems. Symptoms of these conditions may include frequent urination, strong sudden urges to urinate that are hard to control, or involuntary loss of urine (incontinence). By relaxing the muscles in the bladder, fesoterodine improves your ability to control your urination. It helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom. This medication belongs to the class of drugs known as antispasmodics. In 2023, this provider wrote 41 Medicare prescriptions for Toviaz, about 2 times the volume of the typical New York prescriber of this medication (21). Medicare paid an average of $410.00 per fill, versus $490.60 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 41 30-Day Fills standardized to 30-day supplies 1,230 Days of Medication total across all patients in 2023 | |||
| MyrbetriqMirabegron | 35 | $507.69▼ below NY avg | ▼ Less than typical |
About Myrbetriq: This medication is used to treat certain bladder problems (overactive bladder, neurogenic detrusor overactivity). Show more ▾ Overactive bladder is a problem with how your bladder stores urine. Neurogenic detrusor overactivity is a bladder control condition caused by brain, spinal cord, or nerve problems. Symptoms of these conditions may include frequent urination, strong sudden urges to urinate that are hard to control, or involuntary loss of urine (incontinence). Mirabegron works by relaxing a certain bladder muscle (detrusor), which helps the bladder hold more urine and lessens symptoms of overactive bladder and neurogenic detrusor overactivity. In 2023, this provider wrote 35 Medicare prescriptions for Myrbetriq, about 63% of the volume of the typical New York prescriber of this medication (56). Medicare paid an average of $507.69 per fill, versus $638.19 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 37 30-Day Fills standardized to 30-day supplies 1,110 Days of Medication total across all patients in 2023 | |||
| Fesoterodine Fumarate ErFesoterodine Fumarate | 23 | $229.91 | ▲ More than typical |
About Fesoterodine Fumarate Er: This medication is used to treat certain bladder problems (overactive bladder, neurogenic detrusor overactivity). Show more ▾ Overactive bladder is a problem with how your bladder stores urine. Neurogenic detrusor overactivity is a bladder control condition caused by brain, spinal cord, or nerve problems. Symptoms of these conditions may include frequent urination, strong sudden urges to urinate that are hard to control, or involuntary loss of urine (incontinence). By relaxing the muscles in the bladder, fesoterodine improves your ability to control your urination. It helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom. This medication belongs to the class of drugs known as antispasmodics. In 2023, this provider wrote 23 Medicare prescriptions for Fesoterodine Fumarate Er, about 1.4 times the volume of the typical New York prescriber of this medication (16). Medicare paid an average of $229.91 per fill, versus $191.59 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 23 30-Day Fills standardized to 30-day supplies 690 Days of Medication total across all patients in 2023 | |||
| Alfuzosin Hcl ErAlfuzosin Hcl | 18 | $19.10▼ below NY avg | ▼ Less than typical |
About Alfuzosin Hcl Er: Alfuzosin is used by men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). Show more ▾ It does not shrink the prostate, but it works by relaxing the muscles in the prostate and the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Alfuzosin belongs to a class of drugs known as alpha blockers. Do not use this medication to treat high blood pressure. In 2023, this provider wrote 18 Medicare prescriptions for Alfuzosin Hcl Er, about a third of the volume of the typical New York prescriber of this medication (56). Medicare paid an average of $19.10 per fill, versus $26.32 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 26 30-Day Fills standardized to 30-day supplies 780 Days of Medication total across all patients in 2023 | |||
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $36.40 | ▼ Less than typical |
About Nitrofurantoin Mono-Macro: This medication is an antibiotic used to treat bladder infections (acute cystitis). Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. This medication should not be used in infants younger than 1 month old (see also Precautions section). This drug should not be used to treat infections outside the bladder (including kidney infections such as pyelonephritis or perinephric abscesses). In 2023, this provider wrote 12 Medicare prescriptions for Nitrofurantoin Mono-Macro, about half the volume of the typical New York prescriber of this medication (24). Medicare paid an average of $36.40 per fill, versus $22.79 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 148 Days of Medication total across all patients in 2023 | |||
| Levofloxacin | 11 | $2.29▼ below NY avg | ▼ Less than typical |
About Levofloxacin: This medication is used to treat a variety of bacterial infections. Show more ▾ Levofloxacin belongs to a class of drugs known as quinolone antibiotics. It works by stopping the growth of bacteria. Levofloxacin injection is used if you cannot take the medication by mouth. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. The L-isomer of Ofloxacin. In 2023, this provider wrote 11 Medicare prescriptions for Levofloxacin, about half the volume of the typical New York prescriber of this medication (26). Medicare paid an average of $2.29 per fill, versus $8.82 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 11 30-Day Fills standardized to 30-day supplies 105 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. RON S. BAKAL MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Urology prescribing approach at this New York, NY practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among NY prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
